Upregulated N‐cadherin expression is associated with poor prognosis in epithelial‐derived solid tumours: A meta‐analysis

Upregulated N‐cadherin expression is associated with poor prognosis in epithelial‐derived... INTRODUCTIONAs a life‐threatening disease, cancer has increasingly been a heavy burden of healthcare system. The failure of cancer therapy and poor outcomes are mostly owing to the development of local invasion and distant metastasis. Activating of invasion and metastasis has been demonstrated as one of the most important hallmark capabilities of cancer. To date, researchers have paid tremendous attention to the biological behaviour of cancer cells, aiming at finding potential therapeutic targets.Invasion and metastasis are considered as complex processes involving detachment of cancer cell from primary tumour site and formation of new tumour foci in distant organs. Epithelial‐mesenchymal transition (EMT), a developmental regulatory programme, identified as transformed epithelial cells loss epithelial constraints and then acquire the abilities to invade, resist apoptosis and metastasis, which is believed to play a vital role in broadly regulating invasion and metastasis. Cadherins are a family of calcium‐dependent glycoproteins, which responsible for Ca2+‐dependent cell‐cell adhesions. Of the members of this family, N‐cadherin (neuronal cadherin or cadherin‐2), a transmembrane glycoprotein, which is normally expressed in neuroectodermal and mesenchymal‐derived tissues, plays crucial role in lots of processes, such as cell‐cell adhesion, embryogenesis, gastrulation, neurulation, migration and invasion. Today, N‐cadherin is regarded as a vital marker of http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png European Journal of Clinical Investigation Wiley

Upregulated N‐cadherin expression is associated with poor prognosis in epithelial‐derived solid tumours: A meta‐analysis

Loading next page...
 
/lp/wiley/upregulated-n-cadherin-expression-is-associated-with-poor-prognosis-in-N6ygrUJJa3
Publisher
Wiley Subscription Services, Inc., A Wiley Company
Copyright
Copyright © 2018 Stichting European Society for Clinical Investigation Journal Foundation. Published by John Wiley & Sons Ltd
ISSN
0014-2972
eISSN
1365-2362
D.O.I.
10.1111/eci.12903
Publisher site
See Article on Publisher Site

Abstract

INTRODUCTIONAs a life‐threatening disease, cancer has increasingly been a heavy burden of healthcare system. The failure of cancer therapy and poor outcomes are mostly owing to the development of local invasion and distant metastasis. Activating of invasion and metastasis has been demonstrated as one of the most important hallmark capabilities of cancer. To date, researchers have paid tremendous attention to the biological behaviour of cancer cells, aiming at finding potential therapeutic targets.Invasion and metastasis are considered as complex processes involving detachment of cancer cell from primary tumour site and formation of new tumour foci in distant organs. Epithelial‐mesenchymal transition (EMT), a developmental regulatory programme, identified as transformed epithelial cells loss epithelial constraints and then acquire the abilities to invade, resist apoptosis and metastasis, which is believed to play a vital role in broadly regulating invasion and metastasis. Cadherins are a family of calcium‐dependent glycoproteins, which responsible for Ca2+‐dependent cell‐cell adhesions. Of the members of this family, N‐cadherin (neuronal cadherin or cadherin‐2), a transmembrane glycoprotein, which is normally expressed in neuroectodermal and mesenchymal‐derived tissues, plays crucial role in lots of processes, such as cell‐cell adhesion, embryogenesis, gastrulation, neurulation, migration and invasion. Today, N‐cadherin is regarded as a vital marker of

Journal

European Journal of Clinical InvestigationWiley

Published: Jan 1, 2018

Keywords: ; ; ;

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial